Enanta pharmaceuticals reports financial results for its fiscal third quarter with conference call and webcast today at 4:30 p.m. et

Watertown, mass.--(business wire)--enanta pharmaceuticals, inc. (nasdaq:enta), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal third quarter ended june 30, 2023. “our fiscal third quarter was marked by important progress in our pipeline, most notably across our rsv and covid-19 programs. in rsv, we were pleased to report positive phase 1 results for edp-323 in healthy volunteers, demonstratin.
ENTA Ratings Summary
ENTA Quant Ranking